Humedix Co Ltd (200670) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.037x

Based on the latest financial reports, Humedix Co Ltd (200670) has a cash flow conversion efficiency ratio of 0.037x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.71 Billion ≈ $6.58 Million USD) by net assets (₩265.23 Billion ≈ $179.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Humedix Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Humedix Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Humedix Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Humedix Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Humedix Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Platinum Group Metals Ltd TO:PTM	-0.014x
Maritime Resources Corp. V:MAE	0.038x
Mulia Boga Raya PT JK:KEJU	0.038x
S H Kelkar and Company Limited NSE:SHK	0.098x
SICHUAN ENG.INV.DEV.H YC1 F:84H	N/A
Skue Sparebank OL:SKUE	0.056x
RCI Hospitality Holdings Inc NASDAQ:RICK	0.051x
Principal Capital Public Company Limited BK:PRINC	0.018x

Annual Cash Flow Conversion Efficiency for Humedix Co Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of Humedix Co Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 200670 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩228.53 Billion ≈ $154.87 Million	₩50.74 Billion ≈ $34.39 Million	0.222x	+42.39%
2023-12-31	₩198.06 Billion ≈ $134.22 Million	₩30.89 Billion ≈ $20.93 Million	0.156x	-43.14%
2022-12-31	₩139.11 Billion ≈ $94.27 Million	₩38.15 Billion ≈ $25.86 Million	0.274x	+80.11%
2021-12-31	₩125.99 Billion ≈ $85.38 Million	₩19.18 Billion ≈ $13.00 Million	0.152x	-23.06%
2020-12-31	₩120.07 Billion ≈ $81.37 Million	₩23.76 Billion ≈ $16.10 Million	0.198x	+60.66%
2019-12-31	₩112.10 Billion ≈ $75.97 Million	₩13.81 Billion ≈ $9.36 Million	0.123x	-45.07%
2018-12-31	₩106.13 Billion ≈ $71.93 Million	₩23.80 Billion ≈ $16.13 Million	0.224x	+176.11%
2017-12-31	₩107.92 Billion ≈ $73.13 Million	₩8.77 Billion ≈ $5.94 Million	0.081x	+16.47%
2016-12-31	₩109.11 Billion ≈ $73.94 Million	₩7.61 Billion ≈ $5.16 Million	0.070x	-34.59%
2015-12-31	₩109.80 Billion ≈ $74.41 Million	₩11.71 Billion ≈ $7.93 Million	0.107x	--

About Humedix Co Ltd

KQ:200670 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$200.77 Million

₩296.25 Billion KRW

Market Cap Rank

#16640 Global

#636 in Korea

Share Price

₩28800.00

Change (1 day)

+1.77%

52-Week Range

₩24400.00 - ₩75800.00

All Time High

₩75800.00